FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/12/099332 [Registered on: 17/12/2025] Trial Registered Prospectively
Last Modified On: 16/12/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Biological
Dentistry 
Study Design  Other 
Public Title of Study   A study to check the effect of injectable platelet rich fibrin on the speed of canine tooth movement during braces treatment. 
Scientific Title of Study   Comparison of rate of maxillary canine retraction with and without submucosally administered injectable platelet-rich fibrin (i-prf) among orthodontic cases indicated for first premolar extraction – a split mouth study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr. DHARINI M 
Designation  Senior Lecturer 
Affiliation  Dayananda sagar college of dental sciences , affiliated to Rajiv Gandhi University of Health Sciences 
Address  Department of Orthodontics and Dentofacial Orthopaedics,5TH floor, Dental Block Dayananda Sagar College of Dental Sciences. Shavige Malleshwara Hills, Bangalore- 560 111, Karnataka, India
Kumaraswamy Layout, Bangalore 560 111, Karnataka, India
Bangalore
KARNATAKA
560111
India 
Phone  09164198727  
Fax  -  
Email  dharinim@dscds.edu.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Aravind M 
Designation  Professor 
Affiliation  Dayananda Sagar college of dental sciences, affiliated to Rajiv Gandhi University of Health Sciences 
Address  Department of Orthodontics and Dentofacial Orthopaedics, 5th floor, Dental block Dayananda Sagar College of Dental Sciences. Shavige Malleshwara Hills, Kumaraswamy Layout, Bangalore - 560 111, Karnataka, India
Dayananda Sagar College of Dental Sciences. Shavige Malleshwara Hills,Kumaraswamy Layout, Bangalore 560 111, Karnataka, India
Bangalore
KARNATAKA
560111
India 
Phone  9886111436  
Fax  -  
Email  aravindm@dscds.edu.in  
 
Details of Contact Person
Public Query
 
Name  DHARINI M 
Designation  Senior lecturer 
Affiliation  Dayananda sagar college of dental sciences, affiliated to Rajiv Gandhi university of health sciences. 
Address  Department of Orthodontics and Dentofacial Orthopaedics, 5th floor, Dental block, Dayananda Sagar College of Dental Sciences. Shavige Malleshwara Hills, Kumaraswamy Layout, Bangalore 560 111, Karnataka, India
Department of Orthodontics and Dentofacial Orthopaedics, 5th floor, Dental block, Dayananda Sagar College of Dental Sciences. Shavige Malleshwara Hills, Kumaraswamy Layout, Bangalore 560 111, Karnataka, India
Bangalore
KARNATAKA
560111
India 
Phone  09164198727  
Fax  -  
Email  dharinim@dscds.edu.in  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  Dr DHARINI M 
Address  Dayananda Sagar College of Dental Sciences. Shavige Malleshwara Hills, Bangalore- 560111 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr DHARINI M  DAYANANDA SAGAR COLLEGE OF DENTAL SCIENCES  Department of Orthodontics and dentofacial Orthopaedics, 5th floor, Dental block, Dayananda Sagar College of Dental Sciences. Shavige Malleshwara Hills, Kumaraswamy Layout, Bangalore 560111, Karnataka, India
Bangalore
KARNATAKA 
09164198727
-
dharinim@dscds.edu.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
DAYANAND SAGAR COLLEGE OF DENTAL SCIENCES  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Patients with requiring extraction of first maxillary premolars for orthodontic treatment, Angles Class II division 1 malocclusion, Angles Class I Bimaxillary protrusion malocclusion. 
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Injectable platelet rich fibrin  A 10 ml Blood sample will be taken from the patients forearm and collected in a non-silica-coated yellow cap tube of 10 ml. i-PRF is prepared by spinning at 700 rpm for three minutes of centrifugation. The tube obtained after completion of centrifugation shows two different layers with superficial layer being clear liquid PRF and bottom layer being RBCs. The clear fluid about 2ml will be extracted for i-PRF injection, following strict aseptic protocols. After infiltration with local anaesthesia 0.5 mL of i-PRF will be slowly administered submucosally at each of three sites around the experimental maxillary canine at baseline(T0) once, after collecting the intraoral records, and is followed up to 6 months.  
Comparator Agent  local Anaesthesia  Local anaesthetic infiltration of 0.5 mL lignocaine (1:100 000) will be given on each side. The experimental side will receive an additional i-PRF injection at baseline (T0) . 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  35.00 Year(s)
Gender  Both 
Details  Age between 18-35 years, requiring extraction of first maxillary premolars for orthodontic treatment, Class 2 division 1, Bimaxillary protrusion cases 
 
ExclusionCriteria 
Details  Patients with horizontal or vertical bone loss history of bone disorders, poor periodontal health, systemic diseases especially blood dyscrasias, pregnancy, and on steroid therapy, severe skeletal dysplasia in all three dimensions and with poor oral hygiene were excluded from the study.  
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
1)To assess the rate of maxillary canine retraction in experimental site
administered with i-PRF and control site(not administered with i-PRF) at
different time intervals ( baseline T0- T6).


2) To compare the rate of maxillary canine retraction between experimental site
administered with i-PRF and control site (not administered with i-PRF) at
different time intervals ( baseline T0- T6). 
Evaluated at
T0 baseline, 30 days (T1), at 60 days (T2),at 90 days (T3),at 120 days(T4),at 150 days (T 5) and at 180 days(T6 )
 
 
Secondary Outcome  
Outcome  TimePoints 



To compare the rate of maxillary canine retraction within experimental site administered with i-PRF & within control site
(not administered with i-PRF)
at different time intervals ( baseline T0- T6).  
Evaluated at T0-T6
baseline (T0), at 30 days (T1), at 60 days (T2),at 90 days (T3),at 120 days(T4),at 150 days (T 5) & at 180 days(T6). 
To compare the rate of maxillary canine retraction
between male & females. 
Evaluated at T0-T2
baseline (T0), at 30 days (T1), at 60 days (T2). 
 
Target Sample Size   Total Sample Size="24"
Sample Size from India="16" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   02/01/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="7"
Days="25" 
Recruitment Status of Trial (Global)   Open to Recruitment 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Approval for the study was was obtained from the Institutional Review Board of Dayananda Sagar College of Dental Sciences. Consent will be obtained from subjects participating in the study after explaining the purpose and the procedures involved in the study in a language that is understandable by the participants. All patients will be informed of the PRF injection and  applications ,and   informed consent form will be obtained to be a part of the study.

 
Close